Drugs / ChAdOx1
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT05909358 | Jul 2023 → Sep 2027 expected | — | Makerere University | Not yet recruiting | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT04992182 | Jul → Aug 2021 | COVID-19 | Universidad del Desarrollo | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ChAdox1 | “One standard IM ChAdOx1 dose (0.5 mL)” NCT04992182 ↗ |
| Modality | Vaccine | “ChAdox1 candidate vaccine” NCT05909358 ↗ |
| Route | Intramuscular | “0.5 mL IM” NCT04992182 ↗ |